Beijing Quantitative Health Technology Co., Ltd., established on 2014-04-21, The scope of business includes the sale of food;technology development,transfer,Serve;software development;Sales instrumentation,Chemical Products(Free of Hazardous Chemicals),Equipment,Glass product,plastic products,metal products;Import and export,Technology Import and Export,Agent import and export;Natural science research and experimental development,Engineering and Technology Research and Experimental Development,Medical Research and Experimental Development.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Anyuan Pharmaceutical Technology (Shanghai) Co., Ltd. is a Chinese private company located in Shanghai. The firm develops biological macromolecular drugs. It was founded in 2016. Qiang Li is currently the CEO of the company.

Shandong Shanwei Immune Technology Co., Ltd., established on 2020-12-29, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based materials technology;Manufacturing of bio-based materials;Sales of bio-based materials;Natural science research and experimental development;Food Additive Sales;Bio-feed R&D;Feed Raw Material Sales;Feed Additive Sales;Biochemical product technology research and development;Health Consulting Services(Does not include medical services);Healthy food(prepackaged)Sales;Sales of formula food for special medical purposes;food sales(Only sell prepackaged food);Food Internet Sales(Only sell prepackaged food);Food import and export;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:food production;food sales;Food Internet Sales;Health food production;Food additive production;Production of formula food for special medical purpose;Inspection and testing service;Drug import and export;Drug retail;Drug Wholesale;Feed additive production;feed production;pharmaceutical production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines);Pharmaceutical commissioned production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Aixi (Beijing) International Consulting Co., Ltd., established on 2015-07-20, Business scope includes general items:Socioeconomic Advisory Services;trade broker;office services;Business agency service;Corporate Image Planning;marketing planning;Conference and Exhibition Services;Organize cultural and artistic exchange activities;literary creation;Professional Design Services;Graphic design and production;advertising;Advertising Design,acting;translation service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Intellectual Property Services(Except for patent agency services);Agriculture and Gardening Services;Intelligent Agricultural Management;Agricultural Machinery Service;Agricultural Science Research and Experimental Development;Technology related to agricultural production and operation,information,Facilities construction and operation services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:patent agency.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Heilongjiang Rutai Technology Development Co., Ltd., established on 2015-11-30, Business scope includes biomedical research and development,Health product research and development,Medical device research and development,health care consultation,Research and development of chemical materials,Research and development of energy and environmental protection products;Food production and sales,Pharmaceutical production and wholesale.

Shuguang Hospital is a private company headquartered in Shanghai, China, that operates as a hospital.

Shanghai Zhonghua Pharmaceutical Co., Ltd., a subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd., is a company headquartered in Shanghai, China, that manufactures and distributes pharmaceutical products. The firm was acquired by Shanghai Pharmaceuticals Holding Co., Ltd. from Shanghai Pharmaceutical (Group) Co., Ltd. on February 03, 2010 for $27.25 million.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

They are a small molecule drug discovery biotech with an exciting portfolio of research programs that have yielded patent protected drug candidates. Founded in 2010, Curadev has created a premier translational research organization known for prescient target selection and high quality, data-driven program execution. Their programs seek to ameliorate disease by translating cutting edge discoveries into new medicines. They have swiftly established our credentials by successfully creating and out-licensing their small molecule patents in immune-oncology.

Nanjing Zhizheng Pharmaceutical Technology Co., Ltd., established on 2020-06-10, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Sales of Class II Medical Devices;Medical Research and Experimental Development;Cosmetics Wholesale;Cosmetics Retail;Sales of hygiene products and single-use medical products;Personal Hygiene Sales;Engineering and Technology Research and Experimental Development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Domestic trade agent;Health Consulting Services(Does not include medical services);internet sales(Except for products that require a license for sale);Daily miscellaneous goods sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Yiyao Technology Co. Ltd. (doing business as Yiyao Technology) is a Chinese company located in Beijing. The firm operates as an online portal for selling pharmaceutical products. It was founded in 2018 by Zheng Wei Xie and Qian Qian Liu.

Merck Canada, Inc., part of Merck & Co., Inc., is a company headquartered in Kirkland, QC, Canada. The firm manufactures prescription medicines, vaccines, biologic therapies and animal health products. Marwan Akar is the CEO, in this role since 1997.\nThe company says this about itself: For more than 125 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world.

Histoindex Pte Ltd. is a Singaporean company located in Singapore. The firm engages in research and development, manufacturing and distribution of optical medical imaging equipment. It was founded by Gideon Ho and Chi-Shang Tai. Gideon Ho is currently the CEO of the company.\nThe company says this about itself: Founded in Singapore, HistoIndex is a leading MedTech/Healthcare company that specializes in its proprietary integrated stain-free AI digital pathology platform. Enabled by Second Harmonic Generation (SHG) and Two-Photon Excitation (TPE) along with automated imaging analysis algorithms, the integrated platform accurately quantifies histological features and fine measurements that are critical for the evaluation of therapeutic efficacy in clinical trials. The stain-free AI platform is currently involved in multiple FDA clinical trials for Nonalcoholic Steatohepatitis (NASH). In addition, it has benefitted more than 150 research and academic institutes, CROs and biopharma companies around the world in drug discovery and development efforts for fibrotic diseases and cancers.

Wuxi Hisky Medical Technologies Co. Ltd. specializes in developing, manufacturing and marketing of medical equipment for non-invasive liver diagnosis. It focuses on research, application developments as well as the marketing of cutting-edge acoustic technology in the healthcare industry. The company was founded in 2010 and is headquartered in Haidian District, China.